Global Ganja Report

Inauguration of a global hemp research lab has been announced at Oregon State University, where a multidisciplinary team will be working to establish standards for the worldwide industry.

Alexandria Ocasio-Cortez won praise from activists when she decried a white-dominated legal cannabis industry. As if to prove her point, the man she ousted in her 2018 Congressional run, Joe Crowley, is now joining an investment firm linked to the cannabis industry.

Northern Swan, a New York investment house specializing in the cannabis industry, just announced the appointment to two prominent political figures to its advisory board.

The federal bureaucracy is starting to catch up with the law, following passage of the ground-breaking 2018 Farm Bill. The US Patent Office has issued guidelines for trademarks on CBD products, while the Agriculture Department is preparing to recognize intellectual property in hemp varieties.

A new report by the British think-tank Prohibition Partners foresees a $5.8 billion cannabis market in Asia by 2024—if the tentative seeds of liberalization now witnessed across the continent in fact bear fruit.

China's ambition to get in on the "cannabis boom," providing hemp for the global CBD market, is now making international headlines. But marijuana is more harshly proscribed in China than just about any other country in the world, and the People's Republic continues to execute thousands every year for drug crimes.

A new law in Georgia will allow the production of cannabis for medical purposes. The measure gives teeth to a formalistic 2015 law that legalized patient use of low-THC cannabis oil, but still inhibited actual access. Now the Peach State is poised to develop a cannabis business sector.

Idaho is considering legislation that would raise the number of signatures needed to get an initiative on the ballot—in an apparent bid to undercut a medical marijuana legalization effort. Local activists with the Idaho Cannabis Coalition are saying the law would be "tyranny."

The news that CBD products will be arriving at Walgreens and CVS drugstore chains can be seen as further progress for the normalization of cannabis. But it is also a further indication of corporate control of the new cannabis economy.